Latest Breaking News On - Interest disclosures - Page 5 : comparemela.com

Lifestyle Interventions for Obesity in the Era of GLP-1 Receptor Agonists

A central goal of obesity treatment is sustaining weight loss of at least 5%, with at least 10% weight loss conferring greater cardiometabolic health

United kingdomUnited statesEli lillyNovo nordiskCenter blvdWake forest school of medicineNational institutes of healthUnitedhealth groupBoehringer ingelheimNational institutesWake forest schoolMedical center blvdInterest disclosuresNestle healthcare nutritionWeight watchersAmerican board

Text Messages With Financial Incentives for Men With Obesity

This randomized clinical trial assesses whether text messaging combined with financial incentives or text messages alone could help men with obesity lose

United kingdomCity ofGlasgow cityPat hoddinottHealth economics research unitNational institute for health researchNational institute of healthHealth technology assessmentHealth action processSchool for primary care research fundingUnited kingdom office for national statisticsStirling universityScientist officeScotland research ethics committeeNational research scotland primary care networkOffice for national statistics

Cardiovascular Burden of the V142I Transthyretin Variant | Genetics and Genomics | JAMA

Cardiovascular Burden of the V142I Transthyretin Variant | Genetics and Genomics | JAMA
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesUnited kingdomBridgebio pharmaDaiichi sankyoBoehringer ingelheim lillySanofi pasteurBoehringer ingelheimUs department of healthAmerican heart associationMerck sharp dohmeBroad institute of harvardFoundation for sarcoidosis researchBlood instituteDoris duke foundationHuman services

Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger

Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMathews maurerWomen health initiativeNovo nordiskAkcea therapeutics ionis pharmaceuticalsNational heartAmyloidosis programNational institutes of healthNational institute on agingBlood instituteAlnylam pharmaceuticalsColumbia university irving medical centerAtherosclerosis riskMulti ethnic studyRacial differences

Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA

Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

United statesLuba yammineAlireza atriBrandon luckeLance alan sloanEli lillyChristian hendershotJohns hopkins universityBanner sun health research instituteNational institute on drug abuseMichaele debakey va medical centerArizona department of health servicesWashington universityAlzheimer disease internationalYale universityUthealth houston center